Transcription of CANNABIDIOL (CBD) Pre-Review Report - WHO
{{id}} {{{paragraph}}}
Example: bachelor of science
CANNABIDIOL (CBD) Pre-Review Report - WHO
CANNABIDIOL (CBD). Pre-Review Report Agenda Item Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017. 39th ECDD (2017) Agenda item CANNABIDIOL (CBD). Contents Acknowledgements .. 4. Summary .. 5. 1. Substance identification .. 6. A. International Nonproprietary Name (INN) .. 6. B. Chemical Abstract Service (CAS) Registry Number .. 6. C. Other Chemical Names .. 6. D. Trade Names .. 6. E. Street 6. F. Physical Appearance .. 6. G. WHO Review History .. 6. 2. Chemistry .. 6. A. Chemical Name .. 6. B. Chemical 7. C. Stereoisomers .. 7. D. Methods and Ease of Illicit Manufacturing .. 7. E. Chemical Properties .. 9. F. Identification and Analysis .. 9. 3. Ease of Convertibility Into Controlled Substances .. 10. 4. General 11. A. Routes of administration and dosage .. 11. B. Pharmacokinetics .. 11. C. Pharmacodynamics .. 12. 5. 13. 6. Adverse Reactions in Humans .. 13. 7. Dependence Potential .. 14. A. Animal Studies.
CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2 Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: